CT
GSK icon

Chicago Trust’s GSK GSK Stock Holding History

Chicago Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$503K Buy
9,597
+263
+3% +$13.9K 0.07% 243
2026
Q1 		$515K Buy
9,334
+327
+4% +$17.7K 0.08% 233
2025
Q4 		$442K Buy
9,007
+25
+0.3% +$1.17K 0.07% 256
2025
Q3 		$388K Buy
+8,982
New +$351K 0.05% 296

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

Chicago Trust's GSK Position: Q2 2026 in Review

Chicago Trust increased its GSK (GSK) stake by 2.8% in Q2 2026, buying an estimated $13.9K and bringing the position to 9,597 shares worth $503K. The position accounts for 0.07% of the portfolio, ranked #243.

Chicago Trust first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $515K in Q1 2026. 213 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Chicago Trust held 9,597 shares of GSK worth $503K as of Q2 2026.
  • Chicago Trust bought 263 GSK shares in Q2 2026, an estimated $13.9K.
  • GSK made up 0.07% of Chicago Trust's portfolio in Q2 2026, its #243 holding.
  • Chicago Trust first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • Chicago Trust's GSK position peaked at $515K in Q1 2026.
  • 213 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.